ClinicalTrials.govpublic full text
A Study to Evaluate the Efficacy and Safety of Vonoprazan 10 mg Compared to Placebo for Relief of Episodic Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease Through 24 Weeks
symptomatic non-erosive gastroesophageal reflux disease, gerd, vonoprazan, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 857930
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.